WHC is still in active development. Read this to understand our approach.
depiction of CAHCBJPUTCKATP-UHFFFAOYSA-N.svg
isomerdesign

(7R)-7-[(2R)-2-Hydro...

Verificar en isomerdesign

pubchem

19-Propylorvinol

Verificar en pubchem

drugmap

Etorphine

Verificar en drugmap

wiki

Etorphine

Verificar en wiki

Data

InChI: InChI=1S/C25H33NO4/c1-5-8-22(2,28)17-14-23-9-10-25(17,29-4)21-24(23)11-12-26(3)18(23)13-15-6-7-16(27)20(30-21)19(15)24/h6-7,9-10,17-18,21,27-28H,5,8,11-14H2,1-4H3

Sinónimos: (7R)-7-[(2R)-2-Hydroxypentan-2-yl]-6-methoxy-17-methyl-4,5α-epoxy-6α,14α-ethenomorphinan-3-ol,14521-96-1,DEA No. 9056,Propylorvinol,42M2Y6NU9O,BDBM50123599,Etorphinum [INN-Latin], 19-Propylorvinol, Tetrahydro-7-.alpha.-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine,7-alpha-(1-(R)-Hydroxy-1-methylbutyl)-6,14-endo-ethenotetrahydrooripavine,Tetrahydro-7-alpha-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine,6,14-ethenomorphinan-3-ol, 7,8-didehydro-4,5-epoxy-18,19-dihydro-18-[(1R)-1-hydroxy-1-methylbutyl]-6-methoxy-17-methyl-, (5alpha,6beta,14beta,18R)-,M. 99 [as hydrochloride],(-)-Etorphine, 6,14-endo-Ethenotetrahydrooripavine, 7.alpha.-(1-hydroxy-1-methylbuty,UNII-42M2Y6NU9O,ETORPHINE [HSDB],7alpha-Etorphine,6,14-Ethenomorphinan-7-methanol, 4,5-epoxy-3-hydroxy-6-methoxy-alpha,17-dimethyl-alpha-propyl-, (5alpha,7alpha(R))-,6,14-endo-Ethenotetrahydrooripavine, 7-alpha-(1-hydroxy-1-methylbutyl)-,Oripavine, 6,14-endo-ethylenetetrahydro-7-(1-hydroxy-1-methylbutyl)-,ETORPHINE [INN], BDBM82425,M-99 FREE BASE,(4R,4aR,7R,7aR,12bS,14R)-14-[(2R)-2-Hydroxypentan-2-yl]-7-methoxy-3-methyl-1,2,3,4,7,7a-hexahydro-4a,7-ethano-4,12-methano[1]benzofuro[3,2-e]isoquinolin-9-ol, 6,14-Ethenomorphinan-7-methanol, 4,5-epoxy-3-hydroxy-6-methoxy-.alpha.,17-dimethyl-.alpha.-propyl-, [5.alpha.,7.alpha.(R)]-,(5α,6β,14β,18R)-18-[(2R)-2-Hydroxypentan-2-yl]-6-methoxy-17-methyl-7,8-didehydro-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol,HSDB 7601,IDS-NE-007(SECT.3),TETRAHYDRO-7.ALPHA.-(1-HYDROXY-1-METHYLBUTYL)-6,14-ENDO-ETHENOORIPAVINE,7,8-DIHYDRO-7.ALPHA.-(1(R)-HYDROXY-1-METHYLBUTYL)-O SUP(6)-METHYL-6,14-ENDO-ETHENOMORPHINE,Tetrahydro-7-alpha-(2-hydroxy-2-pentyl)-6,14-endo-ethenooripavine,EINECS 238-535-9,Etorphinum,M. 99 FREE BASE,6,14-Ethenomorphinan-7-methanol, 4,5-epoxy-3-hydroxy-6-methoxy-alpha,17-dimethyl-alpha-propyl-, (alphaR,5alpha,7alpha)- (9CI), SCHEMBL10031275,Etorphine (except hydrochloride salt),Etorphine, L024016,6,14-endo-Ethenotetrahydrooripavine, 7alpha-((R)-1-hydroxy-1-methylbutyl)- (8CI),CHEBI:4912,IDS-NE-007,SCHEMBL20507,(5.ALPHA.,7.ALPHA.(R))-4,5-EPOXY-3-HYDROXY-6-METHOXY-.ALPHA.,17-DIMETHYL-.ALPHA.-PROPYL-6,14-ETHENOMORPHINAN-7-METHANOL, ETORPHINE - HCI, M99,Oripavine, 6,14-endo-ethylenetetrahydro-7-(1-hydroxy-1-methylbutyl)- (7CI),ZINC5561290,ETORPHINE [MI],CHEMBL140050,Etorphine [INN:BAN],7,8-Dihydro-7-alpha-(1-(R)-hydroxy-1-methylbutyl)-O(sup 6)-methyl-6,14-endo-ethenomorphine,6,14-Ethenomorphinan-7-methanol, 4,5-epoxy-3-hydroxy-6-methoxy-alpha,17-dimethyl-a-propyl-, [5alpha,7alpha(R)]-,DTXSID40878669, NSC_61677,Etorfina [DCIT],(7R)-7-[(2R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl-5alpha-4,5-epoxy-6,14-ethenomorphinan-3-ol, CAS_61677, Oripavine, 6,14-endo-ethylenetetrahydro-7-(1-hydroxy-1-methylbutyl)-, CAHCBJPUTCKATP-UHFFFAOYSA-N,6,7,8,14-Tetrahydro-7.alpha.-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine,7-alpha-Etorphine,Etorfina, FT-0668440,7.ALPHA.-(1(R)-HYDROXY-1-METHYLBUTYL)-6,14-ENDO-ETHENOTETRAHYDROORIPAVINE, GTPL1625,TETRAHYDRO-7.ALPHA.-(2-HYDROXY-2-PENTYL)-6,14-ENDO-ETHENOORIPAVINE,M99 Injection, AC1LARGT,6,7,8,14-Tetrahydro-7alpha-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine, 7.alpha.-Etorphine

Estimated data

Solubilidad: -3.778 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 99.4% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.